Induction of Immune Tolerance in Islet Transplantation Using Apoptotic Donor Leukocytes
Allogeneic islet transplantation has become an effective treatment option for severe Type 1 diabetes with intractable impaired awareness due to hypoglycemic events. Although current immunosuppressive protocols effectively prevent the acute rejection associated with initial T cell activation in recip...
Guardado en:
Autores principales: | Naoya Sato, Shigeru Marubashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9218a7a69e449feaf66c1cfcf1f39c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
por: Tatum JA, et al.
Publicado: (2017) -
Second hematopoietic stem cell transplantation with a new haploid-mismatched donor in relapsed patients after first transplantation: prognostic analysis of 11 cases
por: ZHU Panpan, et al.
Publicado: (2021) -
Islet Transplantation Imaging in vivo
por: Zheng L, et al.
Publicado: (2020) -
Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series
por: Nhan Hieu Dinh, et al.
Publicado: (2021) -
Donor-transmitted melanoma after limbal stem cell transplantation
por: Anas Alsara, et al.
Publicado: (2017)